Latest revenue
—
as of 2025-12-31
Latest net income
$-224.5K
as of 2025-12-31
Net margin
—
as of 2025-12-31
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Blank Checks (432 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 7, 2026.
Community sentiment
Where do you think ASCBF is heading?
Price · 5Y
Live market
delayed ≤15 min- Market cap
- —
- Enterprise value
- —
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $13.13
- 52-wk low
- $11.41
- Beta
- —
- Shares out
- —
5-year trend
What this company does
ITEM 1. BUSINESS Introduction A SPAC II Acquisition Corp. (the “Company”) is a blank check company incorporated in the British Virgin Islands as a BVI business company for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Although there is no restriction or limitation on what industry or geographic region our target operates in, it is our intention to pursue prospective targets that are in the high-growth industries that apply cutting edge technologies, such as Proptech and Fintech (the “New Economy Sectors”), with a preference for companies that promote environmental, social and…
AI summary unavailable — showing raw filing excerpt
Generated from ASCBF's filing dated 2026-02-17
Key risks
ITEM 1A. RISK FACTORS As a smaller reporting company, we are not required to include risk factors in this Annual Report. However, in addition to the “Risk Factors” section to the Prospectus filed with the SEC on May 3, 2022 and our Form 10-K filed with the SEC on March 27, 2025, we believe the various risks as set forth below could have a material effect on the Company and its operations. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks could arise that may also affect our business or ability to consummate an initial business combination. We may disclose changes to such risk factors or…
AI summary unavailable — showing raw filing excerpt
Generated from ASCBF's filing dated 2026-02-17
Profitability
Return on equity
2.9%
126.1%Return on assets
-38.3%
335.6%Leverage
Debt / equity
-1.08×
36.5%Debt / assets
1401.0%
474.4%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | — | — | $-72.3K | -19.0% | — |
Q4 2025 2025-12-31 | — | — | $-89.8K | -116.7% | — |
Q3 2025 2025-09-30 | — | — | $-56.6K | +12.6% | — |
Q2 2025 2025-06-30 | — | — | $-17.3K | -112.5% | — |
Q1 2025 2025-03-31 | — | — | $-60.7K | -142.7% | — |
Q4 2024 2024-12-31 | — | — | $538.9K | — | — |
Q3 2024 2024-09-30 | — | — | $-64.7K | -106.5% | — |
Q2 2024 2024-06-30 | — | — | $138.3K | -93.9% | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Blank Checks · SIC 6770
Your notes
Keep private notes on ASCBF — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$9.0M
Net activity
−$9.0M
Distinct insiders
1
Open-market trades over the last 365 days.
Recent transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| 2025-07-07 | Anson Chan Director | Sale | 5,000,000 | — | — | |
| 2025-07-07 | Anson Chan Director | Salederiv. | 8,966,000 | $1.00 | $9.0M |
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ASCBF
No institutional holdings on file for ASCBF yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once ASCBF's latest filing finishes processing.
Sign in to vote. Votes use 7-day half-life decay.
Sign in to tap. 7-day half-life decay.